Non-invasive Prenatal Testing Market Growth with Trends, CAGR of 13.80%, Analysis by Type, Application, Regions, Restraints, Top Key Players Profile and forecast to 2029

Non-Invasive Prenatal Testing Market research report displays key data and information about several factors which helps achieve success in the competitive marketplace. Summary of the market is analysed with respect to market players who are mainly customers, businesses or clients. SWOT analysis is the standard, prominent and full-proof method to perform the market research study which is used to formulate this particular Non-Invasive Prenatal Testing Market report. To be ahead of the competition, a systematic idea about the competitive landscape, their product range, their strategies, and future prospects are very important. Market risks and entry barriers makes Healthcare industry aware and help deciding further moves.

After introducing next-generation sequencing technology, it is now possible to sequence foetal DNA fragments that can be built into a whole genetic map, allowing the foetal genome to be inspected prenatally and non-invasively. Novel screening approaches for foetal chromosomal aneuploidies have been developed as a result of advances in molecular technologies and the identification of cell-free foetal DNA in maternal plasma.

Data Bridge Market Research analyses that the non-invasive prenatal testing market which was USD 3.22 billion in 2021, would rocket up to USD 9.06 billion by 2029, and is expected to undergo a CAGR of 13.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-non-invasive-prenatal-testing-market

Non-invasive prenatal testing is a DNA-based blood test that is used to assess the risk of genetic disorders in the developing foetus. This is done to see if you have Down syndrome, Patau syndrome, or Edwards syndrome, among other things.

Some of the major players operating in the non-invasive prenatal testing market are:

Illumina, Inc. (U.S)
Thermo Fisher Scientific Inc. (U.S)
General Electric (U.S)
BGI Group (China)
Agilent Technologies, Inc. (U.S)
F. Hoffmann-La Roche Ltd. (Switzerland)
PerkinElmer Inc. (U.S)
Laboratory Corporation of America Holdings (U.S)
Natera, Inc. (U.S)
Yourgene Health (U.S)
Eurofins LifeCodexx GmbH (Germany)
Quest Diagnostics Incorporated (U.S)
Myriad Genetics Inc. (U.S)
NIPD Genetics (Cyprus)
Next Biosciences (South Africa)

Non-invasive Prenatal Testing Market Dynamics

Drivers

High risk of chromosomal abnormalities with increasing maternal age

The age of a woman at the time of delivery is referred to as her maternal age. Increasing maternal age can lead to a variety of health issues, including reduced fertility, high blood pressure, and an increased chance of miscarriage, stillbirths, and maternal mortality. Furthermore, as a result of faulty chromosomal division, maternal age can raise the incidence of genetic abnormalities in newborns. Microcephaly, a short neck, upward slanted eyes, weak muscular tone, and heart, intestinal, and breathing difficulties are all possible outcomes in neonates. These data imply that there has been an increase in maternal advanced age over the world, which is likely to lead to more health issues. Thus, the increasing maternal age, coupled with the increasing incidence of chromosomal abnormalities, is expected to drive the demand for NIPT tests.

Growing incidence of chromosomal abnormalities

The rising frequency of chromosomal abnormalities, as well as increased product utilisation in new applications, are driving the market's organic revenue growth. Furthermore, innovations in existing tests in terms of expanded functionality, improved chemistry, and bioinformatics analysis are projected to drive market growth. The improvement of payment policies for ordinary and low-risk pregnancies is one of the market's primary driving forces. Natera announced in December 2020 that its non-invasive prenatal testing (NIPT) would be covered for all pregnancies by Aetna, the leading U.S. health insurer.

High incidence rate of down syndrome

One of the key factors driving the market for non-invasive prenatal testing (NIPT) is the rise in average maternal age, which has raised concerns about the fetus's safety. Down syndrome is a chromosomal disorder in which an extra chromosome 21 is formed as a result of a cell division error, and it can damage a foetus' cognitive abilities and physical growth. The NIPT screening tests are safe for both the mother and the baby, pose no risk of miscarriage, and can detect more than 99 percent of Down syndrome instances. According to the National Down Syndrome Society and the Centers for Disease Control and Prevention, one out of every 700 babies in the United States is born with Down syndrome, and 80 percent of Down syndrome children are born to older moms. The increased risk of having babies with Down syndrome among older women drives the non-invasive prenatal testing market.

Global Non-invasive Prenatal Testing Market Scope

The non-invasive prenatal testing market is segmented on the basis of product, method, application, test type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

Products
Consumables
Assay Kits and Reagents
Disposables
Instruments
NGS Systems
PCR Instruments
Microarrays
Ultrasound Devices
Other Instruments
Services

Method

Ultrasound Detection

Biochemical Screening Tests

Cell-free DNA in Maternal Plasma Tests

Application

Trisomy
Microdeletion Syndrome
Other Applications

Test Type

Materni21
Harmony
Panorama
Verify
NIFTY
Others

Technology

NGS
WGS
Others

End-User

Diagnostic Laboratories
Hospitals

Browse More Reports

https://markettreports.blogspot.com/2023/10/arthritis-market-analysis-demand-growth.html

https://markettreports.blogspot.com/2023/10/europe-surface-disinfectants-market.html

https://markettreports.blogspot.com/2023/10/blood-gas-analyzer-market-trends.html

https://markettreports.blogspot.com/2023/10/skin-microbiome-market-trends-share.html

About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com

This release was published on openPR.